BR0013416A - Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone - Google Patents

Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone

Info

Publication number
BR0013416A
BR0013416A BR0013416-3A BR0013416A BR0013416A BR 0013416 A BR0013416 A BR 0013416A BR 0013416 A BR0013416 A BR 0013416A BR 0013416 A BR0013416 A BR 0013416A
Authority
BR
Brazil
Prior art keywords
drug
group
bisphosphonate
treating
fractured bone
Prior art date
Application number
BR0013416-3A
Other languages
Portuguese (pt)
Inventor
David Graham Little
Original Assignee
Royal Alexandra Hosp Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hosp Children filed Critical Royal Alexandra Hosp Children
Publication of BR0013416A publication Critical patent/BR0013416A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"DROGA, USO DE UMA DROGA SELECIONADA DO GRUPO QUE CONSISTE DE PELO MENOS UM BISFOSFONATO, E, MéTODO PARA TRATAMENTO DE UM OSSO FRATURADO". Um droga selecionada de um grupo que consiste de bisfosfonatos para promover o crescimento de osso e para o tratamento de uma fratura."DRUG, USE OF A DRUG SELECTED FROM THE GROUP THAT CONSISTS OF AT LEAST ONE BISPHOSPHONATE, AND, METHOD FOR TREATING A FRACTURED BONE". A drug selected from a group consisting of bisphosphonates to promote bone growth and to treat a fracture.

BR0013416-3A 1999-08-19 2000-08-17 Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone BR0013416A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures
PCT/AU2000/000982 WO2001013922A1 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Publications (1)

Publication Number Publication Date
BR0013416A true BR0013416A (en) 2002-04-30

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013416-3A BR0013416A (en) 1999-08-19 2000-08-17 Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone

Country Status (16)

Country Link
EP (1) EP1214079A4 (en)
JP (1) JP2003507426A (en)
KR (1) KR20020027562A (en)
CN (1) CN100345548C (en)
AU (1) AUPQ232599A0 (en)
BR (1) BR0013416A (en)
CA (1) CA2381302A1 (en)
HK (1) HK1048441B (en)
HU (1) HUP0202396A3 (en)
IL (1) IL148166A0 (en)
NO (1) NO20020784L (en)
NZ (1) NZ517538A (en)
PL (1) PL353485A1 (en)
SK (1) SK2382002A3 (en)
WO (1) WO2001013922A1 (en)
ZA (1) ZA200202160B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK9862003A3 (en) * 2001-02-06 2004-02-03 Royal Alexandra Hosp Children A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
NZ528659A (en) * 2001-04-03 2005-02-25 Royal Alexandra Hosp Children A drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
ES2561463T3 (en) * 2003-08-21 2016-02-26 Addbio Ab Implant device coated with bisphosphonate and method for it
AU2004273672A1 (en) * 2003-09-19 2005-03-31 Wisconsin Alumni Research Foundation Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
ITMI20040218A1 (en) * 2004-02-10 2004-05-10 Abiogen Pharma Spa USE OF SODIUM NERHYDRONATE TO PROMOTE BONE NEOFORMATION
ITMI20040641A1 (en) * 2004-03-31 2004-06-30 Tb Technology S R L BIFUNCTIONAL BIOADHESIVE COMPOSITIONS FOR ORAL IMPLANTOLOGY
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
KR101315925B1 (en) * 2005-10-27 2013-10-08 토멘 메디칼 아게 Dental implant and production method for said implant
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (en) * 1981-11-19 1983-07-05 Luiz Romariz Duarte ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION
JPH07502507A (en) * 1991-12-17 1995-03-16 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド Method for treating osteoporosis using bisphosphonates and parathyroid hormone
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
JPH11506750A (en) * 1995-06-06 1999-06-15 メルク エンド カンパニー インコーポレーテッド Bisphosphonate therapy for bone defects associated with rheumatoid arthritis
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
NZ517538A (en) 2003-07-25
KR20020027562A (en) 2002-04-13
CN1370071A (en) 2002-09-18
HUP0202396A3 (en) 2005-02-28
CA2381302A1 (en) 2001-03-01
HK1048441B (en) 2008-02-22
IL148166A0 (en) 2002-09-12
NO20020784D0 (en) 2002-02-18
EP1214079A4 (en) 2004-03-24
WO2001013922A1 (en) 2001-03-01
CN100345548C (en) 2007-10-31
PL353485A1 (en) 2003-11-17
NO20020784L (en) 2002-02-18
JP2003507426A (en) 2003-02-25
HUP0202396A2 (en) 2002-11-28
EP1214079A1 (en) 2002-06-19
AUPQ232599A0 (en) 1999-09-09
SK2382002A3 (en) 2002-09-10
ZA200202160B (en) 2003-08-27
HK1048441A1 (en) 2003-04-04

Similar Documents

Publication Publication Date Title
ES2138067T3 (en) PROCESS FOR THE TREATMENT OF A SURGICAL IMPLANT.
BRPI0007487B8 (en) diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors
BR0010524A (en) Treatment of refractory human tumors with epidermal growth factor receptor antagonists
BR0014767A (en) Plant seed fibers and use
FI971974A (en) Thienopyridine or thienopyrimidine derivatives and their use
BR0016058A (en) Phosphonate Compounds
BR0107942A (en) Slow Release Protein Polymers
WO2002041837A3 (en) Treatment of mucositis
SE9901272D0 (en) New improved formulation
AR005987A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
PT938326E (en) SYNTHESE PHOSPHOPEPIDES FOR THE TREATMENT OF BONE DISEASES
ATE232874T1 (en) PROSTAGLANDIN CONJUGATES FOR THE TREATMENT OF BONE DISEASES
BR0112350A (en) Compound, pharmaceutical composition, and method of treating an animal afflicted with a neurological or psychological disorder
BR0013416A (en) Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone
ATE443527T1 (en) 5-CNAC FOR ORAL ADMINISTRATION OF PARATHORMONE FRAGMENTS
BR0212757A (en) Composition, method for producing a growth factor composition, and method for treating a bone, tendon, or cartilage defect
ATE225171T1 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF STROKE
BR9811643A (en) Chemical bone supplementation
ATE275580T1 (en) METHOD FOR INDUCING THE PRODUCTION OF GROWTH FACTORS
CY1110156T1 (en) Substituted Compounds 4,5,6,7-tetrahydro-benzothiiazol-2-ylamine
BR0015781A (en) Pharmaceutical composition for treatment of diseases associated with decreased bone mass
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
ATE289201T1 (en) PREPARATION FOR THE TREATMENT OF SURFACE, OPEN WOUNDS
BR9708037A (en) Method for the treatment of substance abuse
BR9709007A (en) Use of substituted azaspirane in the treatment of asthma.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: REFERENTE A RPI NO 2011 DE 21/07/2009.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 10(VIII), 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.